{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:10Z","timestamp":1792782790557,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"von Bodelschwingh Stiftung"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG 422589384"],"award-info":[{"award-number":["DFG 422589384"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004389","name":"Heidehof Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004389","id-type":"DOI","asserted-by":"publisher"}]},{"name":"von Bodelschwingh Stiftung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00415-019-09457-z","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T13:02:27Z","timestamp":1562072547000},"page":"2554-2559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Discontinuing antiepileptic drugs in long-standing idiopathic generalised epilepsy"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-4001","authenticated-orcid":false,"given":"Bernd J.","family":"Vorderw\u00fclbecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kirschbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Merkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philine","family":"Senf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Holtkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"issue":"4","key":"9457_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshe SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM (2017) ILAE classification of the epilepsies: position paper of the ILAE Commission for Class Terminol. Epilepsia 58(4):512\u2013521. \n                    https:\/\/doi.org\/10.1111\/epi.13709","journal-title":"Epilepsia"},{"issue":"11","key":"9457_CR2","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1111\/j.1528-1167.2005.00277.x","volume":"46","author":"S Grosso","year":"2005","unstructured":"Grosso S, Galimberti D, Vezzosi P, Farnetani M, Di Bartolo RM, Bazzotti S, Morgese G, Balestri P (2005) Childhood absence epilepsy: evolution and prognostic factors. Epilepsia 46(11):1796\u20131801. \n                    https:\/\/doi.org\/10.1111\/j.1528-1167.2005.00277.x","journal-title":"Epilepsia"},{"issue":"4","key":"9457_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/epi.12551","volume":"55","author":"AT Berg","year":"2014","unstructured":"Berg AT, Levy SR, Testa FM, Blumenfeld H (2014) Long-term seizure remission in childhood absence epilepsy: might initial treatment matter? Epilepsia 55(4):551\u2013557. \n                    https:\/\/doi.org\/10.1111\/epi.12551","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"9457_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.eplepsyres.2008.11.011","volume":"83","author":"PM Callenbach","year":"2009","unstructured":"Callenbach PM, Bouma PA, Geerts AT, Arts WF, Stroink H, Peeters EA, van Donselaar CA, Peters AC, Brouwer OF (2009) Long-term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood. Epilepsy Res 83(2\u20133):249\u2013256. \n                    https:\/\/doi.org\/10.1016\/j.eplepsyres.2008.11.011","journal-title":"Epilepsy Res"},{"issue":"Suppl 2","key":"9457_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1528-1167.2006.00706.x","volume":"47","author":"M Beghi","year":"2006","unstructured":"Beghi M, Beghi E, Cornaggia CM, Gobbi G (2006) Idiopathic generalized epilepsies of adolescence. Epilepsia 47(Suppl 2):107\u2013110. \n                    https:\/\/doi.org\/10.1111\/j.1528-1167.2006.00706.x","journal-title":"Epilepsia"},{"issue":"7","key":"9457_CR6","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/epi.13761","volume":"58","author":"BJ Vorderwulbecke","year":"2017","unstructured":"Vorderwulbecke BJ, Kowski AB, Kirschbaum A, Merkle H, Senf P, Janz D, Holtkamp M (2017) Long-term outcome in adolescent-onset generalized genetic epilepsies. Epilepsia 58(7):1244\u20131250. \n                    https:\/\/doi.org\/10.1111\/epi.13761","journal-title":"Epilepsia"},{"issue":"2","key":"9457_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/ane.13042","volume":"139","author":"M Syvertsen","year":"2019","unstructured":"Syvertsen M, Flogstad I, Enger U, Landmark CJ, Koht J (2019) Antiepileptic drug withdrawal in juvenile myoclonic epilepsy. Acta Neurol Scand 139(2):192\u2013198. \n                    https:\/\/doi.org\/10.1111\/ane.13042","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"9457_CR8","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.eplepsyres.2014.09.008","volume":"108","author":"J Hofler","year":"2014","unstructured":"Hofler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E (2014) Seizure outcome in 175 patients with juvenile myoclonic epilepsy\u2014a long-term observational study. Epilepsy Res 108(10):1817\u20131824. \n                    https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.09.008","journal-title":"Epilepsy Res"},{"key":"9457_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13811","author":"R Stevelink","year":"2018","unstructured":"Stevelink R, Koeleman BP, Sander JW, Jansen FE, Braun KP (2018) Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors. Eur J Neurol. \n                    https:\/\/doi.org\/10.1111\/ene.13811","journal-title":"Eur J Neurol"},{"issue":"24","key":"9457_CR10","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/01.wnl.0000437303.36064.f8","volume":"81","author":"P Senf","year":"2013","unstructured":"Senf P, Schmitz B, Holtkamp M, Janz D (2013) Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors. Neurology 81(24):2128\u20132133. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000437303.36064.f8","journal-title":"Neurology"},{"issue":"11","key":"9457_CR11","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/epi.12751","volume":"55","author":"M Holtkamp","year":"2014","unstructured":"Holtkamp M, Senf P, Kirschbaum A, Janz D (2014) Psychosocial long-term outcome in juvenile myoclonic epilepsy. Epilepsia 55(11):1732\u20131738. \n                    https:\/\/doi.org\/10.1111\/epi.12751","journal-title":"Epilepsia"},{"issue":"2","key":"9457_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24103","volume":"75","author":"M Holtkamp","year":"2014","unstructured":"Holtkamp M, Kowski AB, Merkle H, Janz D (2014) Long-term outcome in epilepsy with grand mal on awakening: forty years of follow-up. Ann Neurol 75(2):298\u2013302. \n                    https:\/\/doi.org\/10.1002\/ana.24103","journal-title":"Ann Neurol"},{"issue":"6","key":"9457_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1136\/jnnp-2017-317052","volume":"89","author":"M Holtkamp","year":"2018","unstructured":"Holtkamp M, Janz D, Kirschbaum A, Kowski AB, Vorderwulbecke BJ (2018) Absence epilepsy beyond adolescence: an outcome analysis after 45 years of follow-up. J Neurol Neurosurg Psychiatry 89(6):603\u2013610. \n                    https:\/\/doi.org\/10.1136\/jnnp-2017-317052","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"9457_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00415-004-0521-1","volume":"251","author":"E Trinka","year":"2004","unstructured":"Trinka E, Baumgartner S, Unterberger I, Unterrainer J, Luef G, Haberlandt E, Bauer G (2004) Long-term prognosis for childhood and juvenile absence epilepsy. J Neurol 251(10):1235\u20131241. \n                    https:\/\/doi.org\/10.1007\/s00415-004-0521-1","journal-title":"J Neurol"},{"issue":"1","key":"9457_CR15","first-page":"75","volume":"75","author":"A Nicolson","year":"2004","unstructured":"Nicolson A, Appleton RE, Chadwick DW, Smith DF (2004) The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry 75(1):75\u201379","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"9457_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.seizure.2011.03.007","volume":"20","author":"M Pavlovic","year":"2011","unstructured":"Pavlovic M, Jovic N, Pekmezovic T (2011) Antiepileptic drugs withdrawal in patients with idiopathic generalized epilepsy. Seizure 20(7):520\u2013525. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2011.03.007","journal-title":"Seizure"},{"issue":"7","key":"9457_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1474-4422(17)30114-X","volume":"16","author":"HJ Lamberink","year":"2017","unstructured":"Lamberink HJ, Otte WM, Geerts AT, Pavlovic M, Ramos-Lizana J, Marson AG, Overweg J, Sauma L, Specchio LM, Tennison M, Cardoso TMO, Shinnar S, Schmidt D, Geleijns K, Braun KPJ (2017) Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. Lancet Neurol 16(7):523\u2013531. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(17)30114-X","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09457-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09457-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09457-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T20:19:15Z","timestamp":1593548355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09457-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["9457"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09457-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"29 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Martin Holtkamp received speaker\u2019s honoraria and\/or consultancy fees from Bial, Desitin, Eisai, LivaNova, Novartis, and UCB. All the other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the institutional review board at Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin and was, therefore, conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All interviewed patients or their next-of-kin gave written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}